News related to Zelnorm (Tegaserod) and/or conditions it is approved for
Zelnorm Has Serious Side Effects Alert
Source: MedicineNet tegaserod Specialty [2007.04.02]
Title: Zelnorm Has Serious Side Effects Alert
Category: Health News
Created: 4/29/2004
Last Editorial Review: 4/2/2007
IBS Drug Zelnorm Taken Off U.S. Market
Source: MedicineNet tegaserod Specialty [2007.03.30]
Title: IBS Drug Zelnorm Taken Off U.S. Market
Category: Health News
Created: 3/30/2007
Last Editorial Review: 3/30/2007
Ironwood And Forest Present Positive Phase 2b Study Results For Linaclotide In Patients With Irritable Bowel Syndrome With Constipation
Source: Irritable-Bowel Syndrome News From Medical News Today [2008.10.08]
Ironwood Pharmaceuticals, Inc. (formerly Microbia, Inc.) and Forest Laboratories, Inc. (NYSE: FRX) announced the presentation of results from a Phase 2b study assessing linaclotide's safety and efficacy in 420 patients with irritable bowel syndrome with constipation (IBS-C).
Salix Presents New Phase II Data Evidence Demonstrating The Clinical Utility Of Rifaximin In Irritable Bowel Syndrome (IBS)
Source: Irritable-Bowel Syndrome News From Medical News Today [2008.10.06]
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced findings from two analyses of a Phase II clinical trial that demonstrate the utility of rifaximin, a non-absorbed, gut-selective antibiotic, in the treatment of patients with diarrhea-predominant irritable bowel syndrome (IBS).
Is Yakult Helpful In The Treatment Of Irritable Bowel Syndrome?
Source: Irritable-Bowel Syndrome News From Medical News Today [2008.09.12]
SIBO is a common feature in IBS and in fact may be directly related to the genesis of IBS symptoms. An ERBHAL on a lactulose breath test may indicate SIBO. Antibiotics and elemental diets have been shown to be effective in treating SIBO, but the efficacy of probiotics is untested. A pilot study was undertaken to determine the effect of L. strain Shirota (Yakult(R)) on intestinal fermentation patterns of IBS patients.
Allergy Disorders Linked With Irritable Bowel Syndrome
Source: MedicineNet Nasal Allergy Medications Specialty [2008.02.18]
Title: Allergy Disorders Linked With Irritable Bowel Syndrome
Category: Health News
Created: 2/17/2008 2:00:00 AM
Last Editorial Review: 2/18/2008
Irritable Bowel Syndrome
Source: MedicineNet alosetron Specialty [2007.04.02]
Title: Irritable Bowel Syndrome
Category: Diseases and Conditions
Created: 2/25/2002
Last Editorial Review: 4/2/2007
Irritable Bowel Syndrome Symptoms
Source: MedicineNet alosetron Specialty [2005.10.31]
Title: Irritable Bowel Syndrome Symptoms
Category: Health Facts
Created: 10/19/2005
Last Editorial Review: 10/31/2005
The Validity and Accuracy of the Work Productivity and Activity Impairment Questionnaire -- Irritable Bowel Syndrome Version (WPAI:IBS)
Source: Medscape Primary Care Headlines [2004.08.24]
Is the WPAI modified for IBS valid? Is it useful for quantifying productivity loss?
Alimentary Pharmacology & Therapeutics
Irritable Bowel Syndrome-Functional GI Disorders
Source: Medscape Pharmacotherapy Headlines [2004.06.15]
Leading authorities Nicholas J. Talley, MD, PhD, and Lin Chang, MD, provide clinically focused and comprehensive updates on topical issues in IBS, based on key proceedings from DDW 2004. (CME)
Successful IBS Treatment With Peppermint Oil, Antispasmodics, And Fiber
Source: Complementary Medicine / Alternative Medicine News From Medical News Today [2008.11.15]
According to a study published on bmj.com, doctors should recommend fiber, antispasmodics, and peppermint oil as first-line treatments for irritable bowel syndrome (IBS). Recent proof of the effectiveness of these treatments should also lead to changes in the national guidelines that specify how to manage IBS. Affecting between 5% and 20% of the population, IBS is a condition that causes abdominal pain and irregular bowel movements.
Seven-Year Clinical Trial $8.5 Million Funding For Novel IBS Treatment Developed At UB
Source: Irritable-Bowel Syndrome News From Medical News Today [2008.11.15]
Irritable bowel syndrome is a chronic, debilitating disorder affecting 25 million people in the U.S -- 14-24 percent of women and 5-19 percent of men. No reliable and satisfactory medical treatment exists for the full range of IBS symptoms, which can cause severe physical and psychological distress and deprive sufferers of their quality of life.
Peppermint Oil and Other Simple Remedies Found Effective for IBS
Source: MedPage Today Gastroenterology [2008.11.14]
HAMILTON, Ontario (MedPage Today) -- Some of the simplest and most readily available treatments for irritable bowel syndrome are also among the most effective, researchers here said.
Peppermint Oil, Fiber Can Fight Irritable Bowel (HealthDay)
Source: Y! Health Digestive Health News [2008.11.14]
HealthDay - THURSDAY, Nov. 13 (HealthDay News) -- For some patients, the best
therapy for irritable bowel syndrome (IBS) may be older, cheaper drugs
such as fiber, antispasmodics and peppermint oil, a new study finds.
The Effectiveness Of Probiotics In IBS
Source: Irritable-Bowel Syndrome News From Medical News Today [2008.10.07]
Several studies presented at the American College of Gastroenterology's 73rd Annual Scientific Meeting in Orlando highlight the safety and efficacy of probiotics in improving symptoms and normalizing bowel movement frequency in patients suffering from constipation or diarrhea related to Irritable Bowel Syndrome (IBS).
Ironwood And Forest To Present Positive Data From Linaclotide Phase 2b IBS - C Study At ACG Annual Scientific Conference
Source: Irritable-Bowel Syndrome News From Medical News Today [2008.09.27]
Ironwood Pharmaceuticals (formerly Microbia) and Forest Laboratories, Inc. (NYSE: FRX) announced they will present results of a Phase 2b study investigating linaclotide's safety and efficacy in 419 patients with irritable bowel syndrome with constipation (IBS-C) in a plenary session at the American College of Gastroenterology (ACG) 2008 Annual Scientific Meeting in Orlando, Fla. on October 7, 2008.
IBS study shows benefit from targeted antibiotics
Source: The Doctors Lounge - Gastroenterology
The study findings support the theory that irritable bowel syndrome (IBS) is caused by bacterial overgrowth in the gut.
|
